XML 50 R40.htm IDEA: XBRL DOCUMENT v3.21.1
STOCK BASED COMPENSATION (Details Narrative) - USD ($)
3 Months Ended
Mar. 18, 2021
Jan. 29, 2021
Jan. 13, 2021
Mar. 31, 2021
Mar. 31, 2020
Mar. 31, 2019
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]            
Compensation costs         $ 574,000 $ 750,000
Number of restricted stock award, value       $ 0 0  
Proceeds from exercised option to purchase common stock       $ 2,588,000 $ 306,000  
Options outstanding       3,200,000    
Aggregate intrinsic value of outstanding       $ 21,700,000    
Available for future grant under plan       2,228    
Five Employees [Member]            
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]            
Number of restricted stock award     25,000      
Number of restricted stock award, value     $ 370,000      
Grants vest term     5 years      
Fair value of grant options   $ 2,200,000        
Redeem percentage description   August 2020 groundbreaking Federal National Mortgage Association (“Fannie Mae”) financing at 2.62%,        
Liquidation preference per share   $ 25.00        
Five Employees [Member] | Restricted Stock [Member]            
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period   146,572        
Boardof Directors [Member]            
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]            
Number of common stock award     16,500      
Fair value of grant options     $ 244,000      
Four Employees [Member]            
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]            
Number of restricted stock award 108,500          
Number of restricted stock award, value $ 2,100,000          
Grants vest term 5 years          
Forty Two Participants [Member] | Available For Sale Equity Securities Number Of Shares            
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]            
Grants vest term 5 years          
Fair value of grant options $ 327,000          
Option to purchase common stock 159,400          
Twenty Three Participants [Member] | Available For Sale Equity Securities Number Of Shares            
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]            
Exercised option to purchase common stock       215,000    
Weighted-average exercise price       $ 12.06    
Proceeds from exercised option to purchase common stock       $ 2,600,000    
Aggregate intrinsic value of options exercised       $ 1,300,000